We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock
VINC

Delisted

VINC was delisted on the 22nd of April, 2025.

Back to rankings

56 hedge funds and large institutions have $249M invested in Vincerx Pharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

58% more capital invested

Capital invested by funds: $157M → $249M (+$91.6M)

0% more funds holding

Funds holding: 56 → 56 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

Holders
56
Holders Change
–
Holders Change %
0%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
26
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$20.1M
2
RSCM
Rock Springs Capital Management
Maryland
+$11.7M
3
RCMNY
Rubric Capital Management (New York)
New York
+$11.4M
4
SFM
Sphera Funds Management
Israel
+$6.23M
5
BlackRock
BlackRock
New York
+$5.86M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.53M
2
IC
Ikarian Capital
Texas
-$3.32M
3
ACP
Acuta Capital Partners
California
-$3.19M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3.18M
5
PI
Putnam Investments
Massachusetts
-$2.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$24K +$19K +65 +591%
Legal & General Group
52
Legal & General Group
United Kingdom
$22K +$12K +41 +152%
AIP
53
Ameritas Investment Partners
Nebraska
$16K +$9.34K +32 +178%
TRCT
54
Tower Research Capital (TRC)
New York
$10K +$8.46K +29 +1,450%
TWA
55
TCI Wealth Advisors
Arizona
$1K +$875 +3 New
CAPTRUST Financial Advisors
56
CAPTRUST Financial Advisors
North Carolina
$1K +$1.17K +4 New
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
– -$3.18M -12,645 Closed
PI
58
Putnam Investments
Massachusetts
– -$2.87M -11,052 Closed
JGC
59
J. Goldman & Co
New York
– -$1.51M -5,808 Closed
Millennium Management
60
Millennium Management
New York
– -$663K -2,552 Closed
Creative Planning
61
Creative Planning
Kansas
– -$455K -1,750 Closed
M
62
Murchinson
Ontario, Canada
– -$377K -1,452 Closed
JF
63
Jump Financial
Illinois
– -$260K -1,000 Closed
SC
64
Shay Capital
New York
– -$148K -568 Closed
PCM
65
Penserra Capital Management
California
– -$43K -166 Closed
1 2
3

VINC Hedge Fund Activity: Q3 2021 in Review

56 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Common Stock (VINC) for Q3 2021, worth a combined $249M — up 58% from $157M a quarter earlier.

Fund positioning in VINC was balanced in Q3 2021: 9 funds opened new positions, 9 closed out, 26 added to existing stakes and 13 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $20.1M. The largest seller was Wellington Management Group, cutting an estimated $8.53M.

  • 56 institutional investors held Vincerx Pharma, Inc. Common Stock (VINC) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $249M of Vincerx Pharma, Inc. Common Stock stock for Q3 2021, up 58% quarter-over-quarter.
  • 9 funds opened new Vincerx Pharma, Inc. Common Stock positions in Q3 2021 and 9 closed out, a net change of 0 holders.
  • The largest Vincerx Pharma, Inc. Common Stock buyer in Q3 2021 was Deerfield Management, an estimated $20.1M added.
  • The largest Vincerx Pharma, Inc. Common Stock seller in Q3 2021 was Wellington Management Group, an estimated $8.53M sold.

Based on aggregated 13F filings for Q3 2021.